Pure Global

Ostase® BAP EIA - India CDSCO Medical Device Registration

Ostase® BAP EIA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000339_f35e385eae2f160c8fedbc887828035a_e298e3597937ad96c81ef04a68476a83. This device is marketed under the brand name CTX-I. The license holder is CPC DIAGNOSTICS PVT.LTD, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Ostase® BAP EIA
UID: IMP/IVD/2022/000339_f35e385eae2f160c8fedbc887828035a_e298e3597937ad96c81ef04a68476a83

Brand Name

CTX-I

Device Class

Class B

Approving Authority

CDSCO

Product Information

TheOstase® BAPEIAImmunoenzymetricAssayisaninvitrodeviceindicatedforthe quantitative measurement of bone-specific alkaline phosphatase (CTX-I), an indicator of osteoblastic activity, in human serum. This device is intended to be used as an aid in the managementofpostmenopausalosteoporosisand Paget’sdisease

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing